Large-cap Health Care company Hologic has logged a 0.6% change today on a trading volume of 278,342. The average volume for the stock is 1,366,325.
Hologic, Inc. develops, manufactures, and supplies diagnostics products, medical imaging systems, and surgical products for women's health through early detection and treatment in the United States, Europe, the Asia-Pacific, and internationally. Based in Marlborough, United States the company has 6,944 full time employees and a market cap of $20,108,648,448.
The company is now trading -11.46% away from its average analyst target price of $92.12 per share. The 13 analysts following the stock have set target prices ranging from $85.0 to $100.0, and on average give Hologic a rating of buy.
Over the last year, HOLX shares have gone up 19.4%, which represents a difference of -1.0% when compared to the S&P 500. The stock's 52 week high is $87.88 per share whereas its 52 week low is $59.78. Based on Hologic's compounded average operating margin growth of 72.8% over the last 4 years, its core business remains strong and its strong stock performance may continue in the long term.
| Date Reported | Revenue ($ k) | Cost of Revenue ($ k) | Gross Margins (%) | YoY Growth (%) |
|---|---|---|---|---|
| 2022-09-30 | 4,862,800 | 1,865,400 | 61.64 | -8.53 |
| 2021-09-30 | 5,632,300 | 1,836,500 | 67.39 | 14.26 |
| 2020-09-30 | 3,776,400 | 1,548,900 | 58.98 | 51.81 |
| 2019-09-30 | 3,367,300 | 2,059,200 | 38.85 | n/a |
